Bridging the translational gap to accelerate antimicrobial and diagnostic innovation for CF lung infections and beyond.
Who we are
We are on a mission to accelerate the development of new antimicrobials and diagnostics to improve the lives of people with cystic fibrosis (CF) and others living with chronic infection.
We connect innovators in academia and industry to a uniquely coordinated cross-sector community, providing the expertise, resources, and support needed to navigate complex challenges and translate discoveries into real-world solutions.
Our research agenda has been informed by extensive efforts to understand the research landscape and the needs of the CF infection research community.